355379-05-4

Basic information

• Product Name: 4-(4-methoxycarbonyl-phenyl)-piperidine-1-carboxylic acid tert-butyl ester
• Synonyms: 4-(4-methoxycarbonyl-phenyl)-piperidine-1-carboxylic acid tert-butyl ester
• CAS NO: 355379-05-4
• Molecular Weight: 319.401
• Mol File: 355379-05-4.mol
• Article Data: 13

Chemical Properties

• Boiling Point: 426.4±45.0 °C(Predicted)
• Density: 1.113±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 4-(4-methoxycarbonyl-phenyl)-piperidine-1-carboxylic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(4-methoxycarbonyl-phenyl)-piperidine-1-carboxylic acid tert-butyl ester(355379-05-4)
• EPA Substance Registry System: 4-(4-methoxycarbonyl-phenyl)-piperidine-1-carboxylic acid tert-butyl ester(355379-05-4)

Safety Data

• Hazardous Substances Data: 355379-05-4(Hazardous Substances Data)

Upstream product

• 619-42-1 4-methoxycarbonylphenyl bromide 
• 281235-04-9 methyl 4-(piperidine-4-yl)benzoate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 375853-82-0 tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-1(2H)-pyridinecarboxylate 
• 619-44-3 methyl 4-iodobenzoate 
• 17763-71-2 4-carbomethoxyphenyl triflate 
• 180695-79-8 tert-butyl 4-bromo-1-piperidinecarboxylate 
• 99768-12-4 4-methoxycarbonylphenylboronic acid 
• 301673-14-3 tert-butyl 4-iodopiperidine-1-carboxylate 
• 109384-19-2 t-butyl 4-hydroxy piperidine-1-carboxylate 
• 936130-82-4 methyl 4-(piperidine-4-yl)benzoate hydrochloride 
• 106047-17-0 4-Pyridin-4-yl-benzoic acid methyl ester 
• 1120-87-2 4-bromopyridin 

Downstream Products

• 149353-75-3 4-(1-(tert-butoxycarbonyl)piperidin-4-yl)benzoic acid 
• 936130-82-4 methyl 4-(piperidine-4-yl)benzoate hydrochloride 

Relevant articles and documents

Chimeric compound for targeted degradation of androgen receptor protein, preparation method of chimeric compound and application of chimeric compound in medicine

The invention relates to a chimera compound for targeted degradation of androgen receptor protein, a preparation method of the chimera compound and application of the chimera compound in medicine. Specifically, the invention relates to a chimera (PROTAC) compound for targeted degradation of AR protein of a fused heterocyclic cerebellar protein (cerebellone) E3 ubiquitin ligase ligand as shown in a general formula (IM), a preparation method of the chimera compound, and application of the chimera compound in medicine, and particularly relates to a chimera (PROTAC) compound for targeted degradation of AR protein of a fused heterocyclic cerebellar protein E3 ubiquitin ligase ligand of a fused heterocyclic cerebellar protein E3 ubiquitin ligase ligand.

PYRROLOPYRIMIDINE COMPOUNDS USED AS TLR7 AGONIST

The present invention relates to a pyrrolopyrimidine compound as TLR7 agonist, and particularly relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, a preparation process thereof, a pharmaceutical composition containing such compounds and use thereof for manufacturing a medicament against viral infection.

Pyrrolo pyrimidine ring compound, its use and pharmaceutical composition (by machine translation)

The invention relates to an as TLR7 agonist of the pyrrolo pyrimidine compounds, specifically on a compound of formula (I) compound or its pharmaceutically acceptable salt, preparation method thereof, containing the compounds of the pharmaceutical composition, and its use for the preparation of antiviral drug use. Formula (I) (by machine translation)